Lightcast

Series-B+
lightcast.bio Biotech & Healthcare Cambridge, United Kingdom
Total Funding $27M
Latest Round $27M Series-B+
Last Announced Apr 14, 2026
Investors 6 Backers
Decision Makers 6 Verified

About Lightcast

Explore Lightcast's next-generation platform for single-cell functional analysis. Uncover detailed insights into cellular behaviour to accelerate research, drug discovery, and diagnostic development.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United Kingdom
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website lightcast.bio
Domain Registered Date Mar 22, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $27,000,000 · Venture Round

    fundraisingfox.com

  2. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  3. Milestone

    Website domain registered

    lightcast.bio

Investors & Backers

6
+ND Capital
ARCH Venture Partners
Illumina Ventures
Longwall Venture
M Ventures
OMX Ventures

Funding History

2 Rounds
Venture Round · Apr 14, 2026
Series-B+ · Aug 18, 2023

Founders & Leadership

4

Cameron Frayling

Founder

Work email & phone locked Unlock →

Kevin Knopp

independent director

Work email & phone locked Unlock →

Paul Loeffen

Chief Executive Officer

Work email & phone locked Unlock →

Sarah Taylor

Vice President of Science

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts